Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors

Transplantation

Volumn 97, Issue 3, 2014, Pages 316-324

  Lentine, Krista L ^a   Schnitzler, Mark A ^a   Xiao, Huiling ^a   Axelrod, David ^b   Garg, Amit X ^c   Tuttle Newhall, Janet E ^a   Brennan, Daniel C ^d   Segev, Dorry L ^e  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d WASHINGTON UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Diabetes mellitus; Hypertension; Kidney transplantation; Living donors,Medicare

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HEALTH INSURANCE; HIGH RISK PATIENT; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DONOR; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; RACE DIFFERENCE; RISK FACTOR;

ADULT; AFRICAN AMERICANS; AGED; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MEDICARE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84894077520     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000436731.23554.5e     Document Type: Article

References (36)

1. European Parliament C. Directive 2010/45/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation. Available at: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=CELEX: 32010L0053:en:NOT. Accessed March 15, 2013.
2. U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network (OPTN) Policies. Policy 12.0. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-172.pdf. Accessed March 15, 2013.
3. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459.
4. Cherikh WS, Young CJ, Kramer BF, et al. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant 2011; 11: 1650.
5. Leichtman A, Abecassis M, Barr M, et al. Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant 2011; 11: 2561.
6. Lentine KL, Schnitzler MA, Xiao H, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363: 724.
7. Carter JS, Pugh JA, Monterrosa A. NonYinsulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125: 221.
8. Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818.
9. Nogueira JM, Weir MR, Jacobs S, et al. A study of renal outcomes in African American living kidney donors. Transplantation 2009; 88: 1371.
10. Storsley LJ, Young A, Rush DN, et al. Long-term medical outcomes among Aboriginal living kidney donors. Transplantation 2010; 90: 401.
11. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framing-ham Heart Study. JAMA 2002; 287: 1003.
12. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
13. Garg AX, Prasad GV, Thiessen-Philbrook HR, et al. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86: 399.
14. Doshi MD, Goggins MO, Li L, et al. Medical outcomes in African American live kidney donors: a matched cohort study. Am J Transplant 2013; 13: 111.
15. Lee HY, Choi CS, Birkenfeld AL, et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 2010; 12: 668.
16. National Diabetes Information Clearinghouse (NDIC). National Diabetes Statistics, 2011. Available at: http://diabetes.niddk.nih.gov/dm/pubs/ statistics/#fast. Accessed February 1, 2013.
17. Delmonico F. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation 2005; 79(6 Suppl): S53.
18. AST/ASTS/NATCO/UNOS Joint Societies Work Group. Evaluation of the Living Kidney Donor Y a consensus document from the AST/ASTS/NATCO/UNOS Joint Societies Work Group. Available at: www.asts.org/Tools/Download.aspx?fid=1427. Accessed September 12, 2012.
19. Davis CL, Cooper M. The state of U.S. living kidney donors. Clin J Am Soc Nephrol 2010; 5: 1873.
20. Taler SJ, Messersmith EE, Leichtman AB, et al. Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant 2013; 13: 390.
21. van 't Riet E, Dekker JM, Sun Q, et al. Role of adiposity and lifestyle in the relationship between family history of diabetes and 20-year incidence of type 2 diabetes in U.S. women. Diabetes Care 2010; 33: 763.
22. Doshi M, Garg AX, Gibney E, et al. Race and renal function early after live kidney donation: an analysis of the United States Organ Procurement and Transplantation Network Database. Clin Transplant 2010; 24: E153.
23. Nogueira JM, Weir MR, Jacobs S, et al. A study of renal outcomes in obese living kidney donors. Transplantation 2010; 90: 993.
24. Center for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet 2010. Available at: http://www.cdc.gov/diabetes/pubs/ factsheets/kidney.htm. Accessed February 1, 2013.
25. U.S. Renal Data System. 2012 Atlas of ESRD. Chapter One. Available at: http://www.usrds.org/2012/pdf/v2-ch1-12.pdf. Bethesda, MD
26. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Accessed February 1, 2013.
27. GenoveseG, Friedman DJ, Ross MD, etal. Associationof ApoL1variants with kidney disease in African Americans. Science 2010; 329: 841.
28. Kopp JB, Nelson GW, Sampath K, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129.
29. Friedman DJ, Kozlitina J, Genovese G, et al. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22: 2098.
30. Kanji Z, Powe CE, Wenger JB, et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22: 2091.
31. Reeves-Daniel AM, Depalma JA, Bleyer AJ, et al. The APOL1 Gene and Allograft Survival after Kidney Transplantation. Am J Transplant 2011; 11: 1025.
32. Hebert PL, Geiss LS, Tierney EF, et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999; 14: 270.
33. Lentine KL, Schnitzler MA, Abbott KC, et al. Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol 2009; 4: 1213.
34. Stevens LA, Fares G, Fleming J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 2005; 16: 2439.
35. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
36. U.S. Renal Data System. USRDS 2012 Annual Data Report, Methods Appendix. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://www.usrds.org/2012/pdf/v1-z- appendix-12.pdf. Accessed January 28, 2013.